Egg Donation: A Victory for Reproductive Justice or Another Handmaid’s Tale?
By Chantal Bittner,
Bill of Health
| 02. 04. 2025
Before the United States election in 2024, Margaret Atwood shared a cartoon illustrating the handmaids from her dystopian novel entering a polling booth in their unmistakable red cloaks and white bonnets. Having voted, they transform into unique individuals, discarding the attire symbolizing their reproductive enslavement.
One of the central topics of the election campaign was undoubtedly abortion—a key issue in the fight for reproductive justice. However, reproductive justice encompasses far more than abortion. The egg donation industry has expanded into a multi-billion dollar market. While altruism frequently frames their actions, financial incentives are central to attracting many young women to donate—really, sell—their eggs. Upon closer examination, egg donors play a subordinate role despite being essential for the market to function. This post explores the egg market in the U.S. and Europe, shedding light on its implications for the reproductive rights of third parties involved in the process.
The U.S.: A free market model
In the U.S., egg donation operates as an unregulated free market. Compensation varies widely, reaching up to $250,000 in exceptional cases, with an average payment of approximately $7,000. Efforts by the American Society for Reproductive Medicine (ASRM) to regulate this market through guidelines capping payments failed: ASRM attempted to limit donor remuneration to $10,000. However, two donors sued ASRM, claiming the guidelines violated U.S. antitrust laws by constituting price-fixing. In 2015...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...